Icosagen Cell Factory OÜ
Active Registry code 11107818
OÜ Õssu küla Registered 15 Apr 2005
Icosagen Cell Factory OÜ is a OÜ based in Õssu küla, registry code 11107818, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €2 499 401 with 181 employees.
Turnover
2 499 401 €
↓ 36.8% vs Q2 2026
State taxes
845 809 €
↓ 1.6% vs Q2 2026
Labour taxes
918 512 €
↓ 1.9% vs Q2 2026
Employees
181
+5 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 2.5 mn €above 98% of companiesindustry median 14 442 € · companies in the industry: 318
- Labour taxes per employee 5 075 €above 80% of companiesindustry median 2 218 € · companies in the industry: 234
- Revenue · 2025 8.8 mn €above 98% of companiesindustry median 0 € · companies in the industry: 1 073
- Net profit margin · 2025 -50.0 %above 13% of companiesindustry median 13.5 % · companies in the industry: 597
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 2 499 401 | 845 809 | 918 512 | 181 |
| Q2 2026 | 3 951 657 | 859 868 | 936 603 | 176 |
| Q1 2026 | 4 171 962 | 841 560 | 911 298 | 185 |
| Q4 2025 | 2 917 425 | 853 895 | 920 170 | 180 |
| Q3 2025 | 2 995 432 | 878 797 | 948 072 | 183 |
| Q2 2025 | 2 949 098 | 877 436 | 946 108 | 184 |
| Q1 2025 | 4 591 710 | 967 790 | 1 039 450 | 190 |
| Q4 2024 | 4 547 083 | 695 022 | 744 389 | 184 |
| Q3 2024 | 3 632 695 | 746 582 | 791 527 | 175 |
| Q2 2024 | 5 118 360 | 679 998 | 727 184 | 170 |
| Q1 2024 | 5 879 468 | 801 431 | 852 031 | 170 |
| Q4 2023 | 7 583 415 | 569 189 | 599 328 | 157 |
| Q3 2023 | 4 758 861 | 551 505 | 588 218 | 148 |
| Q2 2023 | 4 708 062 | 577 252 | 538 385 | 140 |
| Q1 2023 | 5 570 616 | 604 233 | 640 958 | 134 |
| Q4 2022 | 4 133 718 | 399 992 | 423 703 | 119 |
| Q3 2022 | 3 938 824 | 391 344 | 414 445 | 116 |
| Q2 2022 | 3 935 976 | 373 636 | 349 548 | 108 |
| Q1 2022 | 4 851 321 | 365 682 | 389 743 | 94 |
Labour taxes per employee per month
1 692 €
Turnover per employee in the quarter
13 809 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 8 771 543 | -4 384 364 | 8 913 982 | 38 484 883 | 14 119 066 | 182 |
| 2024 | 12 916 070 | 848 033 | 8 087 793 | 30 566 808 | 18 503 430 | 167 |
| 2023 | 13 347 905 | 2 475 854 | 6 327 544 | 23 727 980 | 17 655 397 | 134 |
| 2022 | 13 677 072 | 5 967 760 | 4 599 321 | 19 612 178 | 15 179 543 | 102 |
| 2021 | 11 485 597 | 5 332 983 | 2 759 561 | 11 683 832 | 9 211 783 | 67 |
| 2020 | 6 679 291 | 1 743 876 | 1 971 039 | 5 793 374 | 3 878 800 | 50 |
| 2019 | 4 767 928 | 704 429 | 1 505 973 | 3 775 075 | 2 134 924 | 44 |
| 2018 | — | — | — | — | — | 38 |
| 2017 | — | — | — | — | — | 28 |
| 2016 | — | — | — | — | — | 21 |
| 2015 | — | — | — | — | — | 17 |
| 2014 | — | — | — | — | — | 20 |
| 2013 | — | — | — | — | — | 18 |
| 2012 | — | — | — | — | — | 19 |
| 2011 | — | — | — | — | — | 19 |
| 2010 | — | — | — | — | — | 16 |
| 2009 | — | — | — | — | — | 12 |
| 2007 | — | — | — | — | — | 12 |
| 2006 | — | — | — | — | — | 13 |
| 2005 | — | — | — | — | — | 9 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-50.0 %
Net profit / revenue
Return on equity (ROE)
-31.1 %
Net profit / equity
Return on assets (ROA)
-11.4 %
Net profit / assets
Equity ratio
36.7 %
Equity / assets
Debt ratio
63.3 %
Liabilities / assets
Current ratio
2.41
Current assets / current liabilities
Revenue per employee
48 195 €
Revenue / average full-time employees
Labour cost per employee per month
4 081 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 29 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 27 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 11 Jun 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 11 May 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 17 Jun 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 29 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 16 Jun 2020 | Company’s own · audited | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 1 | 500 000 € | Swedbank AS | 22 Oct 2009 – in force |
Board
- Mart UstavBoard member · since 3 Nov 2008
- Nasdaq CSD SEKeeper of the share register · since 28 Sep 2017
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Omanikukonto: ICOSAGEN ASLegal person · 10565884 · 11 504 €
Beneficial owners
- Ene TalpsepMember of a senior management body (management or supervisory board) · since 29 Jun 2021
- Mart UstavIndirect ownership · since 18 Oct 2018
Founders and other persons
- Icosagen ASFounder · 40 000 € · 11 Apr 2005
- Grant Thornton Baltic OÜAudit firm · 15 Feb 2023
Related companies
Activities (EMTAK)
- 72101Research and experimental development on natural sciences and engineering Main
- 96999Other personal service activities n.e.c.
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20028773 / 22 11 May 2023 |
Amendment entry | In force 11 May 2023 |
||
| K 20028773 / 21 13 Dec 2022 |
Commercial pledge amended | In force 13 Dec 2022 |
||
| K 20028773 / M5 8 Dec 2022 |
Ruling to eliminate deficiencies | 23 Dec 2022 | Deficiencies eliminated 13 Dec 2022 |
|
| Ä 20028773 / 20 25 Jun 2019 |
Amendment entry | In force 25 Jun 2019 |
||
| Ä 20028773 / 19 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 20028773 / 18 22 Dec 2017 |
Amendment entry | In force 22 Dec 2017 |
||
| Ä 20028773 / 17 3 Dec 2017 |
Amendment entry | In force 3 Dec 2017 |
||
| Ä 20028773 / 16 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 20028773 / 15 7 Feb 2014 |
Amendment entry | In force 7 Feb 2014 |
||
| Ä 20028773 / 14 27 Jun 2011 |
Amendment entry | In force 27 Jun 2011 |
||
| Ä 20028773 / 13 17 Jun 2010 |
Deletion of activities from the registry card | In force 17 Jun 2010 |
||
| Ä 28773 / 12 6 Nov 2009 |
Amendment entry | In force 6 Nov 2009 |
||
| Ä 28773 / M4 23 Oct 2009 |
Ruling to eliminate deficiencies | 23 Nov 2009 | In force 23 Oct 2009 |
|
| K 47277 22 Oct 2009 |
Commercial pledge entered | In force 22 Oct 2009 |
||
| K 47277 / M1 20 Oct 2009 |
Ruling to eliminate deficiencies | 10 Nov 2009 | In force 20 Oct 2009 |
|
| Ä 28773 / 11 8 May 2009 |
Amendment entry | In force 8 May 2009 |
||
| Ä 28773 / M3 30 Apr 2009 |
Ruling to eliminate deficiencies | 2 Jun 2009 | In force 30 Apr 2009 |
|
| Ä 28773 / M2 23 Feb 2009 |
Ruling to eliminate deficiencies | 30 Mar 2009 | In force 23 Feb 2009 |
|
| Ä 28773 / 10 23 Feb 2009 |
Amendment entry | In force 23 Feb 2009 |
||
| Ä 28773 / 9 30 Oct 2008 |
Amendment entry | In force 3 Nov 2008 |
||
| Ä 28773 / 8 5 Sep 2008 |
Amendment entry | In force 5 Sep 2008 |
||
| Ä 28773 / M1 29 Aug 2008 |
Ruling to eliminate deficiencies (to be served) | 3 Oct 2008 | In force 3 Sep 2008 |
|
| Ä 28773 / 7 7 Jan 2008 |
Amendment entry | In force 7 Jan 2008 |
||
| Ä 28773 / 6 15 Jun 2007 |
Amendment entry | In force 15 Jun 2007 |
||
| Ä 28773 / 5 10 May 2007 |
Amendment entry | In force 10 May 2007 |
||
| Ä 28773 / 4 15 Nov 2006 |
Entry made by the register on its own initiative | In force 16 Nov 2006 |
||
| Ä 28773 / 3 18 Oct 2006 |
Amendment entry | In force 18 Oct 2006 |
||
| Ä 28773 / 2 10 Mar 2006 |
Amendment entry | In force 10 Mar 2006 |
||
| Ä 28773 14 Apr 2005 |
First entry | In force |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data